Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Handbook of Experimental Pharmacology|October 20, 2019
Medication Development for Alcohol Use Disorder: A Focus on Clinical StudiesLorenzo Leggio, Daniel E Falk, Megan L Ryan, et al.Biological Psychiatry|January 17, 2016
Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive DisordersLaura E Kwako, Reza Momenan, Raye Z Litten, et al.Journal of Addiction Medicine|June 18, 2015
Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory AnalysisDaniel E Falk, I-Jen P Castle, Megan Ryan, et al.Contemporary Clinical Trials|August 14, 2016
An exploratory evaluation of Take Control: A novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorderEric G Devine, Megan L Ryan, Daniel E Falk, et al.Substance Abuse|March 2, 2016
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safetyRaye Z Litten, Bonnie B Wilford, Daniel E Falk, et al.Journal of Studies on Alcohol and Drugs|March 22, 2014
Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trialsDaniel E Falk, Raye Z Litten, Raymond F Anton, et al.Neuropharmacology|March 12, 2017
Addictions Neuroclinical Assessment: A reverse translational approachLaura E Kwako, Reza Momenan, Erica N Grodin, et al.Alcoholism, Clinical and Experimental Research|October 15, 2013
Five-year healthcare utilization and costs among lower-risk drinkers following alcohol treatmentAndrea H Kline-Simon, Constance M Weisner, Sujaya Parthasarathy, et al.Alcoholism, Clinical and Experimental Research|March 30, 2002
Using acquired knowledge and new technologies in alcoholism treatment trialsBarbara A Flannery, John P Allen, Helen M Pettinati, et al.Alcoholism, Clinical and Experimental Research|July 30, 2013
The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studiesRaye Z Litten, I-Jen P Castle, Daniel Falk, et al.Pageof 5